• Safe DNA Gel Stain: Precision Nucleic Acid Visualization & D

  2026-05-24

  Discover how Safe DNA Gel Stain advances DNA and RNA gel stain workflows with high sensitivity and safety, and learn its practical role in modern nucleic acid diagnostics—offering insights beyond conventional product guides.

• Synergistic Meiotic Initiation in Mouse SSCs via RA and Nutr

  2026-05-23

  The referenced study presents a technically robust method for inducing meiotic initiation in long-term cultured mouse spermatogonial stem cells (SSCs) by combining retinoic acid (RA) with nutrient restriction. This approach addresses a long-standing limitation in in vitro germ cell research, enabling more faithful recapitulation of early meiotic events outside the mammalian testis.

• ER Stress and Cytokine Storms Drive Prometastatic Tumor Stat

  2026-05-22

  Conod et al. illuminate how tumor cells surviving near-lethal stress acquire stable, prometastatic phenotypes, termed PAMEs, via ER stress and cytokine-driven reprogramming. This paradigm reveals new mechanistic links between cell death, tumor plasticity, and metastatic potential, suggesting actionable targets for metastasis prevention.

• BjuBRC1-1 Negatively Regulates Flowering via BjuFUL Promoter

  2026-05-22

  This study reveals that BjuBRC1-1, a TCP transcription factor in Brassica juncea, delays flowering by directly binding to the BjuFUL promoter and repressing its expression. Through a combination of genetic, molecular, and reporter assays, the research delineates a conserved flowering repression mechanism with implications for crop breeding and photoperiod adaptation.

• HotStart Universal 2X Green qPCR Master Mix: Applied Precisi

  2026-05-21

  Unlock robust, reproducible real-time PCR gene expression analysis with HotStart™ Universal 2X Green qPCR Master Mix. This advanced hot-start Taq polymerase solution streamlines dye-based workflows, enabling sensitive quantification and specific amplification even in complex biological samples.

• DiscoveryProbe™ Protease Inhibitor Library: Reliable Assay S

  2026-05-21

  This article explores real-world laboratory challenges in protease inhibition research and demonstrates how the DiscoveryProbe™ Protease Inhibitor Library (SKU L1035) addresses reproducibility, sensitivity, and workflow needs for biomedical scientists. Scenario-driven Q&A blocks offer practical guidance, with direct links to protocols and evidence for high throughput screening applications.

• TRAF2 Competition by CD40 and STING Drives IRF4 B Cell Activ

  2026-05-20

  This study reveals that competitive binding of CD40 and STING with TRAF2 orchestrates IRF4-mediated B cell activation within tertiary lymphoid structures (TLS) in esophageal squamous cell carcinoma (ESCC). These findings establish TLS presence as an independent prognostic marker and clarify the molecular mechanisms that regulate adaptive immunity in ESCC, providing a foundation for future biomarker and therapeutic development.

• Fluorinated CXCR4 Inhibitor A1 Surpasses AMD3100 in Colorect

  2026-05-20

  Khorramdelazad et al. introduce A1, a novel fluorinated CXCR4 inhibitor, demonstrating superior efficacy over AMD3100 in preclinical colorectal cancer models. Their integrated approach, spanning molecular simulations to in vivo analysis, highlights the therapeutic promise of advanced small-molecule CXCR4 antagonists for cancer metastasis inhibition.

• Deferoxamine Mesylate: Precision Iron Chelation for Metaboli

  2026-05-19

  Explore how Deferoxamine mesylate, a leading iron-chelating agent, enables advanced study of iron metabolism and cellular stress adaptation. This article uniquely integrates new insights on nutrient sensing and lysosomal dynamics to guide next-generation assay design.

• DiscoveryProbe Protease Inhibitor Library: Applied Workflows

  2026-05-19

  The DiscoveryProbe™ Protease Inhibitor Library empowers high-throughput exploration of protease biology, delivering robust, reproducible results for drug discovery and mechanistic research. This guide details practical workflows, troubleshooting strategies, and advanced use-cases, spotlighting how APExBIO's curated inhibitor collection elevates experimental precision across apoptosis, cancer, and infectious disease studies.

• BIRB 796 (Doramapimod): Applied p38α MAPK Inhibition in Infl

  2026-05-18

  BIRB 796 (Doramapimod) enables precise, reproducible modulation of p38α MAPK activity for advanced inflammation and apoptosis assays. Backed by recent mechanistic breakthroughs, this highly selective inhibitor from APExBIO empowers robust experimental workflows and troubleshooting in both cell-based and in vivo research.

• Circ-ECH1 Regulates Ntrk2 via miR-708-5p Competition in BPD

  2026-05-18

  This study identifies circ-ECH1 as a regulator of Ntrk2 expression in bronchopulmonary dysplasia (BPD) by competitively binding miR-708-5p. The findings highlight a novel circRNA-mediated pathway that influences cell survival and fibrosis in hyperoxia-exposed lung cells, suggesting new molecular targets for BPD intervention.

• Dorsomorphin (Compound C): Optimizing AMPK and BMP Pathway I

  2026-05-17

  Dorsomorphin (Compound C) provides researchers with precise control over AMPK activity and BMP signaling, empowering advanced studies in autophagy, iron metabolism, and cellular differentiation. This article delivers workflow-driven protocols, troubleshooting strategies, and direct translation of recent findings into practical assay enhancements, setting APExBIO’s Dorsomorphin apart for reproducibility and experimental clarity.

• Triamcinolone: Technical Guidance for Glucocorticoid Researc

  2026-05-16

  Triamcinolone is a synthetic glucocorticoid agonist optimized for in vitro studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. It addresses the need for precise modulation and reproducible handling in anti-inflammatory and immunosuppression studies, but is not suitable for clinical or diagnostic use.

• L1023 Anti-Cancer Compound Library: Workflow Optimization in

  2026-05-15

  The L1023 Anti-Cancer Compound Library empowers rapid, reproducible high-throughput screening of targeted oncology agents, including kinase and MCL1 inhibitors. By integrating practical workflow refinements and troubleshooting rooted in recent literature, researchers can accelerate discovery and surmount resistance mechanisms in cancer models.

15286 records 5/1020 page Previous Next 12345 下5页 Last page